Search research articles
Contact Us
Filters
Showing results (121-130 of 135) with videos related to
Page
of 14
Sort By:
Lancet (London, England)
|
October 26, 1996
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
G R Simpson, T F Schulz, D Whitby, et al.
Journal of Viral Hepatitis
|
March 27, 2007
The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus
G Kafatos, C Anastassopoulou, A Nardone, et al.
Epidemiology and Infection
|
August 13, 2008
The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries
C G Anastassopoulou, G Kafatos, A Nardone, et al.
Journal of Viral Hepatitis
|
March 7, 2018
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe
G V Papatheodoridis, A Hatzakis, E Cholongitas, et al.
Epidemiology and Infection
|
December 24, 2008
A comparison of hepatitis B seroepidemiology in ten European countries
A Nardone, C G Anastassopoulou, H Theeten, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
July 10, 2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions
D Paraskevis, E Kostaki, G Magiorkinis, et al.
AIDS and Behavior
|
November 11, 2022
Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Lucas Wiessing, V Sypsa, A O Abagiu, et al.
Journal of Viral Hepatitis
|
August 10, 2011
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
A Hatzakis, S Wait, J Bruix, et al.
Journal of Viral Hepatitis
|
January 27, 2016
Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference
G Papatheodoridis, H C Thomas, C Golna, et al.
Antiviral Therapy
|
January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testing
A M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 135) with videos related to
Sort By:
Page
of 14
Lancet (London, England)
|
October 26, 1996
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
G R Simpson, T F Schulz, D Whitby, et al.
Journal of Viral Hepatitis
|
March 27, 2007
The European Sero-Epidemiology Network 2: standardization of assay results for hepatitis B virus
G Kafatos, C Anastassopoulou, A Nardone, et al.
Epidemiology and Infection
|
August 13, 2008
The European Sero-Epidemiology Network 2 (ESEN2): standardization of assay results for hepatitis A virus (HAV) to enable comparisons of seroprevalence data across 15 countries
C G Anastassopoulou, G Kafatos, A Nardone, et al.
Journal of Viral Hepatitis
|
March 7, 2018
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe
G V Papatheodoridis, A Hatzakis, E Cholongitas, et al.
Epidemiology and Infection
|
December 24, 2008
A comparison of hepatitis B seroepidemiology in ten European countries
A Nardone, C G Anastassopoulou, H Theeten, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
|
July 10, 2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissions
D Paraskevis, E Kostaki, G Magiorkinis, et al.
AIDS and Behavior
|
November 11, 2022
Impact of COVID-19 & Response Measures on HIV-HCV Prevention Services and Social Determinants in People Who Inject Drugs in 13 Sites with Recent HIV Outbreaks in Europe, North America and Israel
Lucas Wiessing, V Sypsa, A O Abagiu, et al.
Journal of Viral Hepatitis
|
August 10, 2011
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*
A Hatzakis, S Wait, J Bruix, et al.
Journal of Viral Hepatitis
|
January 27, 2016
Addressing barriers to the prevention, diagnosis and treatment of hepatitis B and C in the face of persisting fiscal constraints in Europe: report from a high level conference
G Papatheodoridis, H C Thomas, C Golna, et al.
Antiviral Therapy
|
January 18, 2005
Updated European recommendations for the clinical use of HIV drug resistance testing
A M Vandamme, A Sönnerborg, M Ait-Khaled, et al.
Page
of 14